RARE PHARMACEUTICAL MANUFACTURING FACILITY INVESTMENT OPPORTUNITY
RWC Medical is pleased to present an outstanding opportunity to acquire one of Perth's largest and most sought-after pharmaceutical manufacturing facilities. Located in the highly desirable Balcatta industrial precinct, just 10km north of Perth's CBD, this premium asset offers exceptional connectivity, long-term investment security, and unparalleled tenant strength.
Investment Highlights:
• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.
• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.
• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.
• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.
• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.
• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.
• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.
• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.
Expressions of Interest Close:
Thursday 24th April 2025, 4:00 PM AEST
For further details or to access the data room, please contact the exclusive sales agents:
Franz Stapelberg - Director | +61 430 655 676 | franz.stapelberg@raywhite.com
Nicolas Milner - Sales Agent | +61 416 433 217 | nicolas.milner@raywhite.com
Investment Highlights:
• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.
• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.
• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.
• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.
• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.
• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.
• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.
• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.
Expressions of Interest Close:
Thursday 24th April 2025, 4:00 PM AEST
For further details or to access the data room, please contact the exclusive sales agents:
Franz Stapelberg - Director | +61 430 655 676 | franz.stapelberg@raywhite.com
Nicolas Milner - Sales Agent | +61 416 433 217 | nicolas.milner@raywhite.com